Form 4: Lam Research CEO Timothy Archer Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Lam Research's CEO, Timothy Archer, exercised stock options and sold shares of common stock on June 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 28, 2024, Timothy Archer, the President and CEO of Lam Research, executed a stock option to acquire 19,347 shares of common stock at a price of $145.73 per share.
- Concurrently, Archer sold a total of 10,032 shares of Lam Research common stock at prices ranging from $1,054.43 to $1,074.40.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2024.
- Following these transactions, Archer directly owns 101,094 shares of Lam Research common stock, excluding shares held indirectly through 401(k) plans and by his spouse.
- The reported amount includes shares subject to unvested restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity under a pre-arranged plan, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock holdings and avoid accusations of insider trading.
- Companies like Applied Materials (AMAT) and ASML also see regular Form 4 filings from their executives related to stock transactions.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, but the pre-arranged nature of the transactions mitigates concerns about insider information.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| February 27, 2024 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| June 28, 2024 | Date of the stock option exercise and stock sales |
| December 06, 2025 | Expiration date of the employee stock options |
| July 02, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.